Anavex Life Sciences Corp (AVXL)

[Investor2014]

“We’re still not sure what causes Alzheimer’s disease, but the prevailing theory is the brain is damaged by a build-up of toxic proteins,” A/Prof Macfarlane said.

“There have been many failed trials attempting to remove these proteins or prevent them being produced.

“The theory behind Anavex 2-73 is that it targets a receptor that, when activated, leads to the removal of these abnormal proteins from brain cells.”

Not a particularly good articulation of theA2-73 MOA, but perhaps everyone have been so brain washed with the Amyloid plaque theory that suggesting something that sounds different will not go down well with an AD patient's family doctor?